A vaccine designed with the help of artificial intelligence has entered human trials in what scientists are calling a world-first moment for medical research and drug development.

Oxford researchers, supported by the Medical Research Council, are developing personalized cancer vaccines using AI, leveraging one of the UK's most powerful supercomputers, Dawn.

Researchers at the University of Cambridge have developed the first-ever vaccine component designed entirely by artificial intelligence, now trialled in humans.